Troy Aikman's melanoma awareness initiative tops dermatology reads for week

News that Pro Football Hall of Famer and former melanoma patient Troy Aikman joined Novartis’ “Melanoma Just Got Personal” initiative was the most-read article of the past week on Healio.com/Dermatology.

Other widely read articles included the FDA warning that a skin whitening cream has a risk of mercury poisoning and study results finding that younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma:

Troy Aikman joins advanced melanoma awareness initiative

Troy Aikman, Pro Football Hall of Famer and a former melanoma patient, has joined Novartis’ new initiative to educate patients and caregivers about advanced melanoma, according to a press release.

The initiative, called “Melanoma Just Got Personal,” will provide educational resources to help people learn more about the disease and support for those with advanced melanoma, according to the release. Read more

Incidence of late reactions to Juvéderm Volbella higher than expected

Patients in Israel who received injections of Juvéderm Volbella in the tear trough area or lips had a higher than expected incidence of late cutaneous reactions, according to study results.

Researchers examined the medical records of 400 patients (360 women; average age, 49.6 years) who were treated with Juvéderm Volbella (hyaluronic acid) filler at four medical centers in Israel. Read more

FDA warns skin whitening cream includes risk of mercury poisoning

The FDA has issued a warning to consumers not purchase a skin whitening cream called “Crema Piel De Seda” because of the risk of mercury poisoning.

An FDA laboratory analysis has identified mercury in the product, according to a MedWatch Safety Alert. Read more

Indoor tanning likely factor in melanoma diagnosis among younger women

Younger women who tanned indoors experienced up to a 6-fold likelihood of developing melanoma, which was particularly true for women in their 20s, according to study results recently published in JAMA Dermatology.

Researchers in Minnesota conducted a population-based case control study of 681 patients (68.3% women) diagnosed with melanoma between 2004 and 2007, and 654 controls patients (68.2% women), aged 25 to 49 years. With Perspective. Read more

Microneedling enhances topical anesthesia application for acne scar treatment

Fractional microneedling plus topical anesthesia decreased pain sensation better than topical anesthesia alone when used prior to microneedling procedures for treating postacne scarring, according to recently published study results.

Researchers studied 15 patients (average age, 25 years; nine males) who were seeking treatment of different types of postacne atrophic scars. Read more